JPMorgan Chase & Co. Purchases 811,349 Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX)
JPMorgan Chase & Co. boosted its stake in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) by 288,736.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 811,630 shares of the biotechnology company’s stock after buying an additional 811,349 shares during the period. JPMorgan Chase & Co.’s holdings in CytomX Therapeutics were worth […]
JPMorgan Chase & Co. boosted its stake in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) by 288,736.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 811,630 shares of the biotechnology company’s stock after buying an additional 811,349 shares during the period. JPMorgan Chase & Co.’s holdings in CytomX Therapeutics were worth […]
